Study: No Suicide Risk for Anti-Smoking Pills Chantix, Zyban ABC News Seven years after U.S. regulators slapped their strictest warning on two popular smoking-cessation medicines citing risks of suicidal behavior, a large international study found no such risk. Now Chantix maker Pfizer and Zyban maker GlaxoSmithKline ... |
Saturday, April 23, 2016
0 comments:
Post a Comment